Free Trial

345,528 Shares of Medical Properties Trust, Inc. $MPT Bought by Envestnet Asset Management Inc.

Medical Properties Trust logo with Real Estate background
Image from MarketBeat Media, LLC.

Key Points

  • Envestnet Asset Management acquired 345,528 shares of Medical Properties Trust valued at approximately $1.6 million, while institutional investors collectively own 71.79% of the company.
  • Analyst sentiment remains negative: Medical Properties Trust has an average rating of “Sell” and a consensus price target of $4.15, with Wells Fargo lowering its target to $3.80.
  • The company declared a quarterly dividend of $0.09 per share, representing an annualized payout of $0.36 and a high yield of approximately 10.8%; shares opened at $3.32, near their one-year low.
  • Five stocks we like better than Medical Properties Trust.

Envestnet Asset Management Inc. acquired a new stake in Medical Properties Trust, Inc. (NYSE:MPT - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 345,528 shares of the company's stock, valued at approximately $1,596,000. Envestnet Asset Management Inc. owned 0.06% of Medical Properties Trust as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently made changes to their positions in MPT. Continuum Advisory LLC bought a new position in Medical Properties Trust during the 2nd quarter worth $31,000. Nykredit A S bought a new position in shares of Medical Properties Trust in the second quarter worth $41,000. OneAscent Family Office LLC acquired a new position in Medical Properties Trust in the second quarter valued at about $49,000. Tidal Investments LLC bought a new stake in Medical Properties Trust during the second quarter worth about $49,000. Finally, Greenspring Advisors LLC bought a new stake in Medical Properties Trust during the second quarter worth about $54,000. Institutional investors and hedge funds own 71.79% of the company's stock.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the stock. Weiss Ratings lowered shares of Medical Properties Trust from a "sell (d+)" rating to a "sell (d)" rating in a research report on Tuesday, August 18th. Royal Bank Of Canada lowered their price objective on shares of Medical Properties Trust from $5.00 to $4.50 and set a "sector perform" rating for the company in a research report on Thursday, June 18th. Finally, Wells Fargo & Company cut their target price on Medical Properties Trust from $5.00 to $3.80 and set an "underweight" rating for the company in a research note on Tuesday, September 1st. One research analyst has rated the stock with a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Sell" and a consensus target price of $4.15.

Check Out Our Latest Report on Medical Properties Trust

Medical Properties Trust Price Performance

Shares of NYSE:MPT opened at $3.32 on Wednesday. The company has a market cap of $1.98 billion, a price-to-earnings ratio of -55.33 and a beta of 1.45. The company has a debt-to-equity ratio of 2.16, a current ratio of 3.12 and a quick ratio of 3.12. The firm has a 50 day simple moving average of $3.95 and a 200 day simple moving average of $4.54. Medical Properties Trust, Inc. has a one year low of $3.20 and a one year high of $6.47.

Medical Properties Trust (NYSE:MPT - Get Free Report) last posted its earnings results on Monday, August 10th. The company reported $0.15 earnings per share for the quarter, hitting analysts' consensus estimates of $0.15. Medical Properties Trust had a negative net margin of 2.96% and a negative return on equity of 0.66%. The firm had revenue of $259.28 million for the quarter. The firm's revenue was up 7.9% compared to the same quarter last year. Research analysts predict that Medical Properties Trust, Inc. will post 0.53 earnings per share for the current fiscal year.

Medical Properties Trust Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, October 8th. Shareholders of record on Thursday, September 10th will be given a $0.09 dividend. The ex-dividend date is Thursday, September 10th. This represents a $0.36 annualized dividend and a yield of 10.8%. Medical Properties Trust's dividend payout ratio (DPR) is currently -600.00%.

Medical Properties Trust Company Profile

(Free Report)

Medical Properties Trust, Inc NYSE: MPT is a real estate investment trust focused on owning and investing in healthcare facilities. The company primarily acquires and leases hospitals and other healthcare properties to healthcare operators under long-term agreements, providing real estate capital that can support facility expansion, modernization and operations.

Its portfolio has historically included general acute-care hospitals, inpatient rehabilitation facilities, behavioral health facilities and other specialized healthcare properties.

Further Reading

Want to see what other hedge funds are holding MPT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medical Properties Trust, Inc. (NYSE:MPT - Free Report).

Institutional Ownership by Quarter for Medical Properties Trust (NYSE:MPT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Medical Properties Trust Right Now?

Before you consider Medical Properties Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medical Properties Trust wasn't on the list.

While Medical Properties Trust currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines